InflaRx N.V. (IFRX) Social Stream



InflaRx N.V. (IFRX): $1.40

0.01 (-0.71%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

Add IFRX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#42 of 346

in industry

INFLARX NV (IFRX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering IFRX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-11 6 $16 $5 $11 $1.35 714.81%
2022-03-24 5 $15 $5 $9.75 $1.35 622.22%
2022-03-31 5 $15 $5 $9.25 $1.35 585.19%
2022-05-13 5 $7 $4 $5.75 $1.35 325.93%
2022-08-08 3 $8 $4 $6.333 $1.35 369.11%
2022-12-22 4 $8 $4 $6.666 $1.35 393.78%
2023-03-23 4 $8 $4 $6 $1.35 344.44%
2023-04-05 4 $25 $10 $15 $1.35 1011.11%
2023-04-06 5 $25 $10 $15 $1.35 1011.11%
2023-05-12 5 $25 $8 $13 $1.35 862.96%
2023-08-11 5 $21 $8 $11.5 $1.35 751.85%
2023-10-11 5 $21 $6 $11 $1.35 714.81%
2023-11-02 5 $21 $6 $11 $1.35 714.81%
2023-11-03 5 $19 $5 $10.25 $1.35 659.26%

The Trend in the Analyst Price Target


Over the past 22 months, IFRX's average price target has gone down $0.75.

Over the past 45 weeks, IFRX's average upside potential has been 255.99%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-21 5 25 8 13.00 4.48 190.18%
2023-05-12 5 25 8 13.00 5.10 154.9%
2023-08-11 5 21 6 11.00 3.78 191.01%
2023-10-11 5 21 6 11.00 2.56 329.69%
2023-11-02 5 19 5 10.25 1.40 632.14%

IFRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.4 4 0 1 0 0 5

The Trend in the Broker Recommendations


Over the past 18 months, IFRX's average broker recommendation rating improved by 0.1.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how INFLARX NV fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1958.61% of that group.
  • In terms of how INFLARX NV fares relative to all US stocks, note that its average analyst price target is greater than 206.44% of that group.
  • In the context of all US stocks, INFLARX NV's number of analysts covering the stock is higher than 367.83% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, INFLARX NV's variance in analysts' estimates is lower than -1541.98% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to INFLARX NV are MBIO, EOLS, and ACET.

Make investment decisions regarding IFRX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!